Anti-human IL6R monoclonal antibody, tocilizumab biosimilar (MRA, atlizumab, rhPM-1)

Home/ Products / Biosimilar Antibodies

PRODUCT

  • SKU

    DMS1114-100ug

  • Size

    100 ug

  • Price

    $350

1
This monoclonal antibody is part of a collection of biosimilar antibodies in reference to those approved or in clinical investigation. The biosimilars are for Research Use Only and should not be used in therapeutic or diagnostic procedures in humans or animals.
target IL6R
alias CD126, gp80, IL-6R-1, IL-6RA, IL6Q, IL6RA, IL6RQ
gene id Uniprote ID: P08887
host species Humanized
reactivity Human
iso type IgG1
formulation Lyophilized from sterile PBS, pH 7.4. Typically, 5% - 8% trehalose is added as a protective agent prior to lyophilization.
reconstitution Reconstitute lyophilized powder with water to a concentration of 100 ug/ml, solubilize at RT for 30 minutes with occasional gentle tapping. It is recommended that 0.1% HSA be added as a carrier protein for long-term storage.
applications ELISA; Flow Cytometry
dilution ELISA 1:5000-10000; Flow Cyt 1:100
shipping Shipped at ambient conditions.
storage Lyophilized form is stable for 1 week at room temperature. Store at -20 °C to -80 °C for 12 months in lyophilized form. After reconstitution, store at 4 °C for 2-7 days or at below -20 °C for up to 3 months.
note Other commonly used names in publications refering to this antibody: MRA, atlizumab, rhPM-1

Images

ELISA plate coated with 2 ug/ml (100 ul/well) Human IL6R, His tagged protein binds to anti-IL6R neutralizing antibody in a linear range of 0.64-80 ng/ml.

HEK293 cell line transfected with irrelevant protein (B) and human IL6R (A) were surface stained with anti-IL6R mAb 1 ug/ml (tocilizumab) followed by Alexa 488-conjugated anti-human IgG secondary antibody.


PRODUCT

  • SKU

    DMS1114-100ug

  • Size

    100 ug

  • Price

    $350

1